A phase 3 trial of Roche’s giredestrant in first-line breast cancer patients has missed its primary endpoint, tarnishing the record of a drug that hit the mark in adjuvant and second-line settings.

Google just keeps on releasing new AI tools. On Wednesday, Google rolled out a new AI music generator called Lyria 3. It's a fairly big upgrade over earlier versions of the model, as it makes music ...

Both dosage regimens of amlitelimab were associated with statistically significant improvements in skin clearance and disease severity vs placebo in the US estimand. Topline data were announced from ...

Baumüller cooperates with ControlEng Corporation to have IPMSM motor model of the DS4 series integrated into sizing software SERVOsoft. The DS4 motor series features interior magnets, is very compact, ...

A phase 3 trial of Sanofi’s eczema prospect amlitelimab has hit its primary and key secondary endpoints. Yet, with the data falling short of analyst expectations, shares in the company opened down 9% ...

Google will increase its $20/month Gemini Pro plan with greater access to its capable Veo 3 Fast video maker, giving users an easier and cheaper entry into high-quality AI content creation. The update ...

Results of a randomized phase III trial of pre-operative chemotherapy with mFOLFIRINOX or PAXG regimen for stage I-III pancreatic ductal adenocarcinoma. This is an ASCO Meeting Abstract from the 2025 ...

Chinese AI lab DeepSeek has released a new image generator, Janus-Pro-7B, which the company says is better than competitors. When you purchase through links on our site, we may earn an affiliate ...